High serum levels of tumour necrosis factor‐α and interleukin‐8 in severe asthma: markers of systemic inflammation?
- 31 May 2006
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 36 (11) , 1373-1381
- https://doi.org/10.1111/j.1365-2222.2006.02502.x
Abstract
Summary: Background Severe asthma is characterized by elevated levels of pro‐inflammatory cytokines and neutrophilic inflammation in the airways. Blood cytokines, markers of ‘systemic’ inflammation, may be a feature of amplified inflammation in severe asthma.Objective To detect differences in IL‐8, TNF‐α, IL‐16 and IL‐13 levels in the serum(s) of stable severe and mild–moderate asthmatics related to blood leucocytes proportion, airway calibre and exhaled nitric oxide (NO) levels.Methods We assessed cytokine serum levels by ELISA and blood leucocyte counts by an alkaline peroxidase method in 20 healthy controls, 22 mild–moderate [forced expiratory volume in 1 s (FEV1)(%pred): 89±3] and 14 severe asthmatics [FEV1(%pred): 49±2].Results IL‐8 and TNF‐α levels were higher in severe asthmatics than in mild–moderate asthmatics or in controls (PPPPr=0.67; P=0.01) or circulating neutrophil counts (r=0.57; P=0.03) in severe asthmatics.Conclusion sTNF‐α and sIL‐8 are markers of ‘systemic’ inflammation in severe asthmatics, in conjunction with augmented circulating neutrophils, suggesting the involvement of neutrophil‐derived cytokine pattern in severe asthma.Keywords
This publication has 49 references indexed in Scilit:
- A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmaticsThe FASEB Journal, 2003
- Effects of inhaled tumour necrosis factor alpha in subjects with mild asthmaThorax, 2002
- A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task forceAllergy, 2001
- InfliximabDrugs, 2000
- Cytokines in asthmaThorax, 1999
- Inhaled and Systemic Corticosteroid Therapies: Do They Contribute to Inspiratory Muscle Weakness in Asthma?Respiration, 1999
- EtanerceptDrugs, 1999
- Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatmentJournal of Allergy and Clinical Immunology, 1997
- New insights into the pathogenesis of severe corticosteroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1996
- Nitric oxide and asthmatic inflammationImmunology Today, 1995